Status:
UNKNOWN
Intravitreal Bevacizumab for Diabetic Macular Edema
Lead Sponsor:
Isfahan Ophthalmology Research Center
Conditions:
Macular Edema
Diabetic Retinopathy
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Diabetic macular edema is a common cause of visual loss among diabetic patients. Studies have demonstrated the role of vascular endothelial growth factor (VEGF) in the pathogenesis of edema. This stu...
Eligibility Criteria
Inclusion
- Diabetes mellitus
- Clinically significant macular edema
- Possibility of performing macular OCT
- Consent of patient for inclusion in the study
Exclusion
- History of macular photocoagulation in less than 6 months of inclusion in the study
- Necessity of surgical intervention
- Rejection of the remaining in the study by patient
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00703235
Last Update
June 23 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.